<!DOCTYPE html>
<html lang="en-us">
<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="theme" content="hugo-academic">
  <meta name="generator" content="Hugo 0.42.2" />
  <meta name="author" content="Steven Xijin Ge">

  
  
  
  
    
      
    
  
  <meta name="description" content="As a scientist who also suffers from vitiligo, I spent a day trying to read the current SCIENTIFIC findings published in peer-reviewed scientific journals.
 Two type of vitiligo: segmental (localized) vs. non-segmental. Most are non-segmental. Some evidence suggests that vitiligo patients are low in antioxidants, vitamin D, zinc, and copper. Vitiligo patients often suffer low glutathione peroxidase (GPx) as suggested by this and other papers. Vitiligo is a loss of pigmentation in the skin.">

  
  <link rel="alternate" hreflang="en-us" href="/post/vitiligo-treatment-protocols/">

  


  

  
  
  <meta name="theme-color" content="#0095eb">
  
  
  
  
    
  
  
    
    
      
        <link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/github.min.css">
      
    
  
  
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha512-6MXa8B6uaO18Hid6blRMetEIoPqHf7Ux1tnyIQdpt9qI5OACx7C+O3IVTr98vwGnlcg0LOLa02i9Y1HpVhlfiw==" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha512-SfTiTlX6kk+qitfevl/7LibUOeJWlt9rbyDn92a1DqWOw9vWG2MFoays0sgObmWazO5BQPiFucnnEAjpAB+/Sw==" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">
  
  
  
  
  <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Montserrat:400,700%7cRoboto:400,400italic,700%7cRoboto&#43;Mono">
  
  <link rel="stylesheet" href="/styles.css">
  

  
  
    <script>
      window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;
      ga('create', 'UA-87863704-4', 'auto');
      
      ga('require', 'eventTracker');
      ga('require', 'outboundLinkTracker');
      ga('require', 'urlChangeTracker');
      ga('send', 'pageview');
    </script>
    <script async src="//www.google-analytics.com/analytics.js"></script>
    
    <script async src="https://cdnjs.cloudflare.com/ajax/libs/autotrack/2.4.1/autotrack.js" integrity="sha512-HUmooslVKj4m6OBu0OgzjXXr+QuFYy/k7eLI5jdeEy/F4RSgMn6XRWRGkFi5IFaFgy7uFTkegp3Z0XnJf3Jq+g==" crossorigin="anonymous"></script>
    
  
  

  
  <link rel="alternate" href="/index.xml" type="application/rss+xml" title="In Data We Trust">
  <link rel="feed" href="/index.xml" type="application/rss+xml" title="In Data We Trust">
  

  <link rel="manifest" href="/site.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="/post/vitiligo-treatment-protocols/">

  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="twitter:site" content="@StevenXGe">
  <meta property="twitter:creator" content="@StevenXGe">
  
  <meta property="og:site_name" content="In Data We Trust">
  <meta property="og:url" content="/post/vitiligo-treatment-protocols/">
  <meta property="og:title" content="Vitiligo Treatment Protocols | In Data We Trust">
  <meta property="og:description" content="As a scientist who also suffers from vitiligo, I spent a day trying to read the current SCIENTIFIC findings published in peer-reviewed scientific journals.
 Two type of vitiligo: segmental (localized) vs. non-segmental. Most are non-segmental. Some evidence suggests that vitiligo patients are low in antioxidants, vitamin D, zinc, and copper. Vitiligo patients often suffer low glutathione peroxidase (GPx) as suggested by this and other papers. Vitiligo is a loss of pigmentation in the skin.">
  <meta property="og:locale" content="en-us">
  
  <meta property="article:published_time" content="2018-07-08T00:00:00&#43;00:00">
  
  <meta property="article:modified_time" content="2018-07-08T00:00:00&#43;00:00">
  

  

  

  <title>Vitiligo Treatment Protocols | In Data We Trust</title>

</head>
<body id="top" data-spy="scroll" data-target="#toc" data-offset="71" >

<nav class="navbar navbar-default navbar-fixed-top" id="navbar-main">
  <div class="container">

    
    <div class="navbar-header">
      
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse"
              data-target=".navbar-collapse" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      
      <a class="navbar-brand" href="/">In Data We Trust</a>
    </div>

    
    <div class="collapse navbar-collapse">

      
      
      <ul class="nav navbar-nav navbar-right">
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#posts">
            
            <span>Posts</span>
            
          </a>
        </li>

        
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#contact">
            
            <span>About</span>
            
          </a>
        </li>

        
        
      

      
      </ul>

    </div>
  </div>
</nav>


<article class="article" itemscope itemtype="http://schema.org/Article">

  


  <div class="article-container">
    <h1 itemprop="name">Vitiligo Treatment Protocols</h1>

    

<div class="article-metadata">

  

  <span class="article-date">
    
    <meta content="2018-07-08 00:00:00 &#43;0000 UTC" itemprop="datePublished">
    <time datetime="2018-07-08 00:00:00 &#43;0000 UTC" itemprop="dateModified">
      Jul 8, 2018
    </time>
  </span>
  <span itemscope itemprop="author publisher" itemtype="http://schema.org/Person">
    <meta itemprop="name" content="Steven Xijin Ge">
  </span>

  
  <span class="middot-divider"></span>
  <span class="article-reading-time">
    3 min read
  </span>
  

  
  
  <span class="middot-divider"></span>
  <a href="/post/vitiligo-treatment-protocols/#disqus_thread"></a>
  

  
  
  
  <span class="middot-divider"></span>
  <span class="article-categories">
    <i class="fa fa-folder"></i>
    
    <a href="/categories/disease/">Disease</a
    >
    
  </span>
  
  

  
  
<div class="share-box" aria-hidden="true">
  <ul class="share">
    <li>
      <a class="twitter"
         href="https://twitter.com/intent/tweet?text=Vitiligo%20Treatment%20Protocols&amp;url=%2fpost%2fvitiligo-treatment-protocols%2f"
         target="_blank" rel="noopener">
        <i class="fa fa-twitter"></i>
      </a>
    </li>
    <li>
      <a class="facebook"
         href="https://www.facebook.com/sharer.php?u=%2fpost%2fvitiligo-treatment-protocols%2f"
         target="_blank" rel="noopener">
        <i class="fa fa-facebook"></i>
      </a>
    </li>
    <li>
      <a class="linkedin"
         href="https://www.linkedin.com/shareArticle?mini=true&amp;url=%2fpost%2fvitiligo-treatment-protocols%2f&amp;title=Vitiligo%20Treatment%20Protocols"
         target="_blank" rel="noopener">
        <i class="fa fa-linkedin"></i>
      </a>
    </li>
    <li>
      <a class="weibo"
         href="http://service.weibo.com/share/share.php?url=%2fpost%2fvitiligo-treatment-protocols%2f&amp;title=Vitiligo%20Treatment%20Protocols"
         target="_blank" rel="noopener">
        <i class="fa fa-weibo"></i>
      </a>
    </li>
    <li>
      <a class="email"
         href="mailto:?subject=Vitiligo%20Treatment%20Protocols&amp;body=%2fpost%2fvitiligo-treatment-protocols%2f">
        <i class="fa fa-envelope"></i>
      </a>
    </li>
  </ul>
</div>


  

</div>


    <div class="article-style" itemprop="articleBody">
      <p>As a scientist who also suffers from vitiligo, I spent a day trying to read the current SCIENTIFIC findings published in peer-reviewed scientific journals.</p>

<ul>
<li>Two type of vitiligo: segmental (localized) vs. non-segmental. Most are non-segmental.</li>
<li>Some evidence suggests that vitiligo patients are low in <a href="http://www.ncbi.nlm.nih.gov/pubmed/27057010" target="_blank">antioxidants</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/26422855" target="_blank">vitamin D</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/24517587" target="_blank">zinc</a>, and <a href="http://www.ncbi.nlm.nih.gov/pubmed/24517587" target="_blank">copper</a>. Vitiligo patients often suffer low glutathione peroxidase (GPx) as suggested by <a href="http://www.ncbi.nlm.nih.gov/pubmed/27218102" target="_blank">this</a> and other papers.</li>
<li>Vitiligo is a loss of pigmentation in the skin. Loss of a type of cells called melanocyte that produces melanin. Pathology is unclear, but the evidence is strong for autoimmune disease. In other words, our immune cells attack melanocytes. Oxidative stress by reactive oxygen species might play a role.</li>
<li>There is no cure for vitiligo. But most patients see improvements with current treatments. It may take months.</li>
<li>Many treatment exits, but few are rigorously tested in controlled clinical trials.  Scientifically sound results published in peer-reviewed scientific journals are available in PubMed.org.</li>
<li>Standard treatment protocols recommended by scientists and doctors, such as the <a href="http://www.espcr.org/vetf/" target="_blank">Vitiligo European Task Force</a>. The following charts are from a book “Pigmentary Disorders: A Comprehensive Compendium” by Koushik Lahiri, Manas Chatterjee, Rashmi Sarka.</li>
</ul>

<p><img src="/img/vitiligo/image001.png" alt="Image1" />
<img src="/img/vitiligo/image003.png" alt="Image2" />
<img src="/img/vitiligo/image005.png" alt="Image3" /></p>

<p>As can be seen from these two figures, the most widely used therapies are Narrow-band ultraviolet B (NB-UVB), topical corticosteroid, topical calcineurin inhibitors.
These therapies can be classified into the following categories:</p>

<ol>
<li>Phototherapy uses different lights to treat vitiligo. Narrow-band ultraviolet B (NB-UVB) is one of the most effective methods. It can be targeted to small areas or the whole body.</li>
<li>Topical therapies such as a topical corticosteroid, topical calcineurin inhibitors (Tacrolimus, pimecrolimus, etc.) are effective for selected areas. But not for long-term use. These are standard recommended methods to try first for segmental vitiligo, small, limited patches. For large areas of vitiligo throughout the body, the standard approach is NB-UVB for three months, in combination with topical therapies.</li>
<li>Systemic treatment can be done through oral medicines such as corticosteroids. Oral corticosteroids are shown to stop the progression of vitiligo and induce repigmentation. But side effects are a concern. Antioxidants, either oral or topical, can help protect against reactive oxygen species that are believed to cause vitiligo.</li>
<li>Surgical therapy. Transplant of skins or even <a href="http://www.ncbi.nlm.nih.gov/pubmed/26865785" target="_blank">hair follicular</a>. Methods such as suction blister epidermal grafts are very effective and safe.<br /></li>
<li>Camouflage. Cosmetic camouflage improves quality of life. Some are permanent (tattoos, and micropigmentation) should be used with caution. Using <a href="http://www.dermnetnz.org/treatments/dihydroxyacetone.html" target="_blank">DHA creams</a> to camouflage seem to be <a href="http://www.ncbi.nlm.nih.gov/pubmed/18377610" target="_blank">safe and effective</a>. These creams are used in self-tanning and will last 5-7 days.</li>
<li>Combination therapy combines these methods.

<ul>
<li>Topical creams are often combined with phototherapy.</li>
<li>Oral MPD mini-pulse therapy combined with NBUVB appears effective in arresting vitiligo progression and rapidly inducing repigmentation with minimal side effects.</li>
<li>The combined treatment with oral ALA, betamethasone injection and NB-UVB was effective and safe on non-segmental progressive vitiligo. ALA could accelerate the initial response of repigmentation.</li>
</ul></li>
<li>Alternative therapy. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18498646" target="_blank">Many</a> are being tested. But their effectiveness are not well supported.

<ul>
<li>Diet supplements such as Vitamin C, E, ginko biloba extracts. Supplements for zinc and copper. L-phenylalanine used with phototherapy, and oral Ginkgo biloba as monotherapy show promise.</li>
<li>Some Chinese herbal medicines act as photosensitizing agents to induce effects like sun burn to treat vitiligo.</li>
<li>Combine vitamin E with phototherapy.</li>
</ul></li>
</ol>

<p>My vitiligo, however, keeps progressing. Hope someday there is a safe and effective cure.</p>

    </div>

    


<div class="article-tags">
  
  <a class="btn btn-primary btn-outline" href="/tags/vitiligo/">Vitiligo</a>
  
</div>




    
    

    

    
<section id="comments">
  <div id="disqus_thread"></div>
<script>
    var disqus_config = function () {
    
    
    
    };
    (function() {
        if (["localhost", "127.0.0.1"].indexOf(window.location.hostname) != -1) {
            document.getElementById('disqus_thread').innerHTML = 'Disqus comments not available by default when the website is previewed locally.';
            return;
        }
        var d = document, s = d.createElement('script'); s.async = true;
        s.src = '//' + "https-gex-netlify-com" + '.disqus.com/embed.js';
        s.setAttribute('data-timestamp', +new Date());
        (d.head || d.body).appendChild(s);
    })();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
<a href="https://disqus.com" class="dsq-brlink">comments powered by <span class="logo-disqus">Disqus</span></a>
</section>



  </div>
</article>

<footer class="site-footer">
  <div class="container">
    <p class="powered-by">

      &copy; 2018 &middot; 

      Powered by the
      <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
      <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

      <span class="pull-right" aria-hidden="true">
        <a href="#" id="back_to_top">
          <span class="button_icon">
            <i class="fa fa-chevron-up fa-2x"></i>
          </span>
        </a>
      </span>

    </p>
  </div>
</footer>


<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close btn-large" data-dismiss="modal">&times;</button>
        <h4 class="modal-title">Cite</h4>
      </div>
      <div>
        <pre><code class="modal-body tex"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-primary btn-outline js-copy-cite" href="#" target="_blank">
          <i class="fa fa-copy"></i> Copy
        </a>
        <a class="btn btn-primary btn-outline js-download-cite" href="#" target="_blank">
          <i class="fa fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

    

    
    
    <script id="dsq-count-scr" src="//https-gex-netlify-com.disqus.com/count.js" async></script>
    

    

    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.2.1/jquery.min.js" integrity="sha512-3P8rXCuGJdNZOnUx/03c1jOTnMn3rP63nBip5gOP2qmUh5YAdVAvFZ1E+QLZZbC1rtMrQb+mah3AfYW11RUrWA==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.3/imagesloaded.pkgd.min.js" integrity="sha512-umsR78NN0D23AzgoZ11K7raBD+R6hqKojyBZs1w8WvYlsI+QuKRGBx3LFCwhatzBunCjDuJpDHwxD13sLMbpRA==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha512-iztkobsvnjKfAtTNdHkGVjAYTrrtlC7mGp/54c40wowO7LhURYl3gVzzcEqGl/qKXQltJ2HwMrdLcNUdo+N/RQ==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.4/isotope.pkgd.min.js" integrity="sha512-VDBOIlDbuC4VWxGJNmuFRQ0Li0SKkDpmGyuhAG5LTDLd/dJ/S0WMVxriR2Y+CyPL5gzjpN4f/6iqWVBJlht0tQ==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>
    
    
    <script src="/js/hugo-academic.js"></script>
    

    
    
      
      
      <script src="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js" integrity="sha256-/BfiIkHlHoVihZdc6TFuj7MmJ0TWcWsMXkeDFwhi0zw=" crossorigin="anonymous"></script>
      

      

      

      <script>hljs.initHighlightingOnLoad();</script>
    

    
    

  </body>
</html>

